Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 23,351 shares at $0.34 ($10K) on 2022-05-13, disclosed to the SEC on 2022-05-19.
Open-market purchase of $10k EMMA by Chairman and CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.60 | 6,000 | $4K | 37.6% |
| 2 | $0.34 | 10,000 | $3K | 35.5% |
| 3 | $0.35 | 7,351 | $3K | 26.9% |
| Total | $0.41 avg | 23,351 | $10K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |